These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 8605115)

  • 1. Mapping of chromosomal gains and losses in prostate cancer by comparative genomic hybridization.
    Joos S; Bergerheim US; Pan Y; Matsuyama H; Bentz M; du Manoir S; Lichter P
    Genes Chromosomes Cancer; 1995 Dec; 14(4):267-76. PubMed ID: 8605115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative genomic hybridization, allelic imbalance, and fluorescence in situ hybridization on chromosome 8 in prostate cancer.
    Cher ML; MacGrogan D; Bookstein R; Brown JA; Jenkins RB; Jensen RH
    Genes Chromosomes Cancer; 1994 Nov; 11(3):153-62. PubMed ID: 7530484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA in situ hybridization (interphase cytogenetics) versus comparative genomic hybridization (CGH) in human cancer: detection of numerical and structural chromosome aberrations.
    Van Dekken H; Krijtenburg PJ; Alers JC
    Acta Histochem; 2000 Feb; 102(1):85-94. PubMed ID: 10726167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular cytogenetics of prostate cancer.
    Nupponen NN; Visakorpi T
    Microsc Res Tech; 2000 Dec; 51(5):456-63. PubMed ID: 11074616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosome arm 20q gains and other genomic alterations in colorectal cancer metastatic to liver, as analyzed by comparative genomic hybridization and fluorescence in situ hybridization.
    Korn WM; Yasutake T; Kuo WL; Warren RS; Collins C; Tomita M; Gray J; Waldman FM
    Genes Chromosomes Cancer; 1999 Jun; 25(2):82-90. PubMed ID: 10337990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping.
    Cher ML; Bova GS; Moore DH; Small EJ; Carroll PR; Pin SS; Epstein JI; Isaacs WB; Jensen RH
    Cancer Res; 1996 Jul; 56(13):3091-102. PubMed ID: 8674067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of genetic alterations in advanced prostate cancer by comparative genomic hybridization.
    Kasahara K; Taguchi T; Yamasaki I; Kamada M; Yuri K; Shuin T
    Cancer Genet Cytogenet; 2002 Aug; 137(1):59-63. PubMed ID: 12377415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosomal changes during development and progression of prostate adenocarcinomas.
    Zitzelsberger H; Engert D; Walch A; Kulka U; Aubele M; Höfler H; Bauchinger M; Werner M
    Br J Cancer; 2001 Jan; 84(2):202-8. PubMed ID: 11161378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosomal aberrations in breast cancer: a comparison between cytogenetics and comparative genomic hybridization.
    Persson K; Pandis N; Mertens F; Borg A; Baldetorp B; Killander D; Isola J
    Genes Chromosomes Cancer; 1999 Jun; 25(2):115-22. PubMed ID: 10337995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization.
    Visakorpi T; Kallioniemi AH; Syvänen AC; Hyytinen ER; Karhu R; Tammela T; Isola JJ; Kallioniemi OP
    Cancer Res; 1995 Jan; 55(2):342-7. PubMed ID: 7529134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of chromosomal imbalances in transitional cell carcinoma of the bladder by comparative genomic hybridization.
    Voorter C; Joos S; Bringuier PP; Vallinga M; Poddighe P; Schalken J; du Manoir S; Ramaekers F; Lichter P; Hopman A
    Am J Pathol; 1995 Jun; 146(6):1341-54. PubMed ID: 7778674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of genetic markers for prostatic cancer progression.
    Alers JC; Rochat J; Krijtenburg PJ; Hop WC; Kranse R; Rosenberg C; Tanke HJ; Schröder FH; van Dekken H
    Lab Invest; 2000 Jun; 80(6):931-42. PubMed ID: 10879743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytogenetic studies in prostate cancer: are we making progress?
    Brothman AR
    Cancer Genet Cytogenet; 1997 May; 95(1):116-21. PubMed ID: 9140461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristic pattern of chromosomal gains and losses in marginal zone B cell lymphoma detected by comparative genomic hybridization.
    Dierlamm J; Rosenberg C; Stul M; Pittaluga S; Wlodarska I; Michaux L; Dehaen M; Verhoef G; Thomas J; de Kelver W; Bakker-Schut T; Cassiman JJ; Raap AK; De Wolf-Peeters C; Van den Berghe H; Hagemeijer A
    Leukemia; 1997 May; 11(5):747-58. PubMed ID: 9180302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel chromosomal abnormalities identified by comparative genomic hybridization in parathyroid adenomas.
    Palanisamy N; Imanishi Y; Rao PH; Tahara H; Chaganti RS; Arnold A
    J Clin Endocrinol Metab; 1998 May; 83(5):1766-70. PubMed ID: 9589690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined study of prostatic carcinoma by classical cytogenetic analysis and comparative genomic hybridization.
    Verdorfer I; Hobisch A; Culig Z; Hittmair A; Bartsch G; Erdel M; Duba HC; Utermann G
    Int J Oncol; 2001 Dec; 19(6):1263-70. PubMed ID: 11713598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic aberrations in prostate carcinoma detected by comparative genomic hybridization and microsatellite analysis: association with progression and angiogenesis.
    Strohmeyer DM; Berger AP; Moore DH; Bartsch G; Klocker H; Carroll PR; Loening SA; Jensen RH
    Prostate; 2004 Apr; 59(1):43-58. PubMed ID: 14991865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of genetic alterations in primary nasopharyngeal carcinoma by comparative genomic hybridization.
    Fang Y; Guan X; Guo Y; Sham J; Deng M; Liang Q; Li H; Zhang H; Zhou H; Trent J
    Genes Chromosomes Cancer; 2001 Mar; 30(3):254-60. PubMed ID: 11170282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interphase cytogenetics of prostatic tumor progression: specific chromosomal abnormalities are involved in metastasis to the bone.
    Alers JC; Krijtenburg PJ; Rosenberg C; Hop WC; Verkerk AM; Schröder FH; van der Kwast TH; Bosman FT; van Dekken H
    Lab Invest; 1997 Nov; 77(5):437-48. PubMed ID: 9389787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic alterations in hormone-refractory recurrent prostate carcinomas.
    Nupponen NN; Kakkola L; Koivisto P; Visakorpi T
    Am J Pathol; 1998 Jul; 153(1):141-8. PubMed ID: 9665474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.